Anti-osteoarthritic Effect of High Bioavailable Curcumin Formulation by Balancing Cartilage Synthesis and Cartilage Degradation in MIA-induced Osteoarthritis Rats

ABSTRACT

Background: Osteoarthritis affects millions of people worldwide. Currently, available pharmacological treatment is limited to topical and oral non-steroidal anti-inflammatory drugs (NSAIDs). Several studies have reported the potential of curcumin in the management of osteoarthritis, owing to its anti-osteoarthritic, anti-inflammatory, and antioxidant effects. However, the poor bioavailability of curcumin limits its safe and effective use in the long-term management of osteoarthritis. Objectives: The present research study was undertaken to understand the anti-osteoarthritis effect of a newly developed, highly bioavailable curcumin formulation, Maxicuma®, at the preclinical level. The anti-osteoarthritic activity was evaluated using the monosodium iodoacetate (MIA)-induced osteoarthritis model in rats at 10 and 25 mg/kg bw doses. Materials and Methods: Anti-inflammatory and antioxidant effects were studied in the MIA-induced osteoarthritis model and the lipopolysaccharide (LPS)-induced mouse macrophages. The extent of efficacy was investigated by examining the expression of catabolic and anabolic genes from the joint capsule, along with histopathology examination of the joint. Results: Maxicuma® administration in osteoarthritic rats reduced the edema of affected knee joints, increased the expression of anabolic gene COL2A1, decreased the expression of catabolic genes MMP-3 and MMP-7, and reduced the glycosaminoglycan contents in the affected knee joints. Chondrocyte scoring through histopathology of the joint tissues has confirmed the anti-osteoarthritic effects of Maxicuma®. Maxicuma® reduced the inflammatory mediators and enhanced the antioxidant defense system in osteoarthritis rats and LPS-induced mouse macrophages. Conclusion: Thus, Maxicuma® showed an anti-osteoarthritic potential by balancing the synthesis and degradation of joint cartilage.

KEYWORDS

• Maxicuma®
• osteoarthritis
• glycosaminoglycans
• chondrocyte scoring
• cartilage synthesis and degradation

Showing references and in-text citations exactly as published.

• DOI10.1177/09731296251326792Copy

RELATED ARTICLES

Matched on section and article type within this issue of Pharmacogn. Mag..

• Article · VOLUME 22, ISSUE 1Leonurine Attenuates Neuroinflammation and Oxidative Stress in a Pentylenetetrazoleinduced Epilepsy in RatsHuan Hui, Fan Li · pp. 113–124Original Research ArticleSame type: Article
• Article · VOLUME 22, ISSUE 1A Comparative Study Between Cheilocostus speciosus (Sea Qust) and Saussurea lappa (Indian Qust): Decoding the Spectral, Anti-bacterial, and Anti-cancer AnalysesSiddig Ibrahim Abdelwahab, Manal Mohamed Elhassan Taha, Syam Mohan, Mukul Sharma, Md Shamsher Alam, Mohamed Eltaib Elmobark, Sivakumar S Moni, Mohammed Albeishy, Ohood Sufyani, Afraim Koty, Adel S. Al-Zubairi · pp. 125–135Original Research ArticleSame type: Article
• Article · VOLUME 22, ISSUE 1Integrate Molecular Docking and Animal Model Validation into the Research of the Effect and Potential Mechanism of Eupatilin Against Myocardial Ischemia/Reperfusion InjuryYulong Li, Xiang Li · pp. 136–146Original Research ArticleSame type: Article
• Article · VOLUME 22, ISSUE 1Albiflorin Enhances Diabetic Wound Healing Process by Enhancing Re-epithelialization and Ameliorating Inflammation and Oxidative Stress in Diabetic RatsJie Yang, Xinrong Zhang, Jiawei Zhang, Lu Yan · pp. 147–157Original Research ArticleSame type: Article